Follow
Youhua Liu
Title
Cited by
Cited by
Year
Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention
Y Liu
Journal of the American Society of Nephrology 15 (1), 1-12, 2004
16392004
Renal fibrosis: new insights into the pathogenesis and therapeutics
Y Liu
Kidney international 69 (2), 213-217, 2006
15262006
Cellular and molecular mechanisms of renal fibrosis
Y Liu
Nature Reviews Nephrology 7 (12), 684-696, 2011
14842011
Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis
J Yang, Y Liu
The American journal of pathology 159 (4), 1465-1475, 2001
11792001
New insights into epithelial-mesenchymal transition in kidney fibrosis
Y Liu
Journal of the American Society of Nephrology 21 (2), 212-222, 2010
11212010
Wnt/β-catenin signaling promotes renal interstitial fibrosis
W He, C Dai, Y Li, G Zeng, SP Monga, Y Liu
Journal of the American Society of Nephrology 20 (4), 765-776, 2009
6812009
Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis
Y Li, J Yang, C Dai, C Wu, Y Liu
The Journal of clinical investigation 112 (4), 503-516, 2003
5832003
Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis
J Yang, Y Liu
Journal of the American Society of Nephrology 13 (1), 96-107, 2002
5232002
Wnt/β-catenin signaling promotes podocyte dysfunction and albuminuria
C Dai, DB Stolz, LP Kiss, SP Monga, LB Holzman, Y Liu
Journal of the American Society of Nephrology 20 (9), 1997-2008, 2009
4802009
Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria
Y Li, YS Kang, C Dai, LP Kiss, X Wen, Y Liu
The American journal of pathology 172 (2), 299-308, 2008
4472008
Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy
X Tan, Y Li, Y Liu
Journal of the American Society of Nephrology 17 (12), 3382-3393, 2006
3892006
Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling
L Zhou, Y Li, D Zhou, RJ Tan, Y Liu
Journal of the American Society of Nephrology 24 (5), 771-785, 2013
3822013
Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action
Y Liu
American Journal of Physiology-Renal Physiology 287 (1), F7-F16, 2004
3722004
Paricalcitol inhibits renal inflammation by promoting vitamin D receptor–mediated sequestration of NF-κB signaling
X Tan, X Wen, Y Liu
Journal of the American Society of Nephrology 19 (9), 1741-1752, 2008
3532008
Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy
J Yang, RW Shultz, WM Mars, RE Wegner, Y Li, C Dai, K Nejak, Y Liu
The Journal of clinical investigation 110 (10), 1525-1538, 2002
3512002
Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury
W He, YS Kang, C Dai, Y Liu
Journal of the American Society of Nephrology 22 (1), 90-103, 2011
3272011
Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation
JL Xia, C Dai, GK Michalopoulos, Y Liu
The American journal of pathology 168 (5), 1500-1512, 2006
2872006
Wnt/β-catenin signaling and kidney fibrosis
RJ Tan, D Zhou, L Zhou, Y Liu
Kidney international supplements 4 (1), 84-90, 2014
2812014
Matrix metalloproteinases in kidney homeostasis and diseases
RJ Tan, Y Liu
American journal of physiology-renal physiology 302 (11), F1351-F1361, 2012
2802012
Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis
S Hao, W He, Y Li, H Ding, Y Hou, J Nie, FF Hou, M Kahn, Y Liu
Journal of the American Society of Nephrology 22 (9), 1642-1653, 2011
2742011
The system can't perform the operation now. Try again later.
Articles 1–20